NREM parasomnias: a treatment approach based upon a retrospective case series of 512 patients
- PMID: 29753639
- PMCID: PMC6558250
- DOI: 10.1016/j.sleep.2018.03.021
NREM parasomnias: a treatment approach based upon a retrospective case series of 512 patients
Erratum in
-
Corrigendum to "NREM parasomnias: a treatment approach based upon a retrospective case series of 512 patients" [Sleep Med 53 (2019) 181-188].Sleep Med. 2020 Jan;65:186. doi: 10.1016/j.sleep.2019.07.001. Epub 2019 Oct 21. Sleep Med. 2020. PMID: 31648902 Free PMC article. No abstract available.
Abstract
Background: Non-REM parasomnias are not uncommon conditions in the general population. Current treatment options are based on small case series and reports. In this study, we aimed to present the clinical experience from a large cohort of patients.
Patients: Five hundred and twelve patients with Non-REM parasomnia or parasomnia overlap disorder (POD), who had undergone a video polysomnography and were exposed to treatment, were retrospectively identified. Treatment outcome was assessed based on patients' reports, and treatment approach on a locally accepted hierarchy of interventions.
Results: Forty percent of patients were diagnosed with sleepwalking, 23.8% with mixed-phenotype and 10% with POD. Ultimately, 97.2% reported adequate control of their symptoms. Moreover, 60.1% were treated with pharmacotherapy and 32.0% without, consistent across all phenotypes (p = 0.09). Benzodiazepines were the most common drugs prescribed (47.1%, p < 0.05). In the end, 37.7% of our patients were receiving a benzodiazepine as part of their successful treatment, 11.7% an antidepressant, 9.2% a z-drug, and 10.7% melatonin. Finally, 13.2%, 12.1%, and 5.8% of our patients reported good control of their symptoms with sleep hygiene, management of sleep-disordered breathing, and psychological interventions (cognitive behavioral therapy [CBT] or mindfulness-based stress reduction [MBSR]), as monotherapy, respectively.
Conclusion: The treatment approach to effective treatment of the patients with Non-REM parasomnias or POD offering first sleep hygiene advice, next treatment of concurrent sleep disorders and management of other priming factors like stress and anxiety, and lastly pharmacotherapy for Non-REM parasomnia is supported by our results. Non pharmacological interventions were effective in one third of our patients, and CBT/MBSR and melatonin appeared promising new treatments.
Keywords: CBT; CPAP; Melatonin; NREM parasomnia; POD; Treatment.
Copyright © 2018 Elsevier B.V. All rights reserved.
Figures
![Fig. 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/6603248/bin/gr1.gif)
![Fig. 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/6603248/bin/gr2.gif)
Similar articles
-
Behavioral and psychological treatments for NREM parasomnias: A systematic review.Sleep Med. 2023 Nov;111:36-53. doi: 10.1016/j.sleep.2023.09.004. Epub 2023 Sep 6. Sleep Med. 2023. PMID: 37716336 Review.
-
Drugs Used in Parasomnia.Sleep Med Clin. 2020 Jun;15(2):289-300. doi: 10.1016/j.jsmc.2020.02.014. Sleep Med Clin. 2020. PMID: 32386702 Review.
-
Video polysomnographic findings in non-rapid eye movement parasomnia.J Sleep Res. 2019 Apr;28(2):e12772. doi: 10.1111/jsr.12772. Epub 2018 Oct 8. J Sleep Res. 2019. PMID: 30295353 Free PMC article.
-
Not Only Sleepwalking But NREM Parasomnia Irrespective of the Type Is Associated with HLA DQB1*05:01.J Clin Sleep Med. 2016 Apr 15;12(4):565-70. doi: 10.5664/jcsm.5692. J Clin Sleep Med. 2016. PMID: 26951409 Free PMC article.
-
Sleepwalking and sleep terrors in prepubertal children: what triggers them?Pediatrics. 2003 Jan;111(1):e17-25. doi: 10.1542/peds.111.1.e17. Pediatrics. 2003. PMID: 12509590
Cited by
-
Melatonin Use in Pediatrics: A Clinical Review on Indications, Multisystem Effects, and Toxicity.Children (Basel). 2024 Mar 9;11(3):323. doi: 10.3390/children11030323. Children (Basel). 2024. PMID: 38539358 Free PMC article. Review.
-
Behavioral and psychological treatments for NREM parasomnias: A systematic review.Sleep Med. 2023 Nov;111:36-53. doi: 10.1016/j.sleep.2023.09.004. Epub 2023 Sep 6. Sleep Med. 2023. PMID: 37716336 Review.
-
Diagnosis and Management of NREM Sleep Parasomnias in Children and Adults.Diagnostics (Basel). 2023 Mar 27;13(7):1261. doi: 10.3390/diagnostics13071261. Diagnostics (Basel). 2023. PMID: 37046480 Free PMC article. Review.
-
Group Cognitive Behavioural Therapy for Non-Rapid Eye Movement Parasomnias: Long-Term Outcomes and Impact of COVID-19 Lockdown.Brain Sci. 2023 Feb 17;13(2):347. doi: 10.3390/brainsci13020347. Brain Sci. 2023. PMID: 36831890 Free PMC article.
-
Non-REM parasomnias: a scoping review of dreams and dreamlike mentation.Croat Med J. 2022 Dec 31;63(6):525-535. doi: 10.3325/cmj.2022.63.525. Croat Med J. 2022. PMID: 36597564 Free PMC article. Review.
References
-
- American Academy of Sleep Medicine. International classification of sleep disorders 3rd ed. American Academy of Sleep Medicine, Darien.
-
- Schenck C.H., Howell M.J. Spectrum of rapid eye movement sleep behavior disorder (overlap between rapid eye movement sleep behavior disorder and other parasomnias) Sleep Biol Rhythm. 2013;11:27–34.
-
- Pressman M.R. Factors that predispose, prime and precipitate NREM parasomnias in adults: clinical and forensic implications. Sleep Med Rev. 2007;11:5–30. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical